Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 06:49 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Gabapentin Dosages for Postoperative Analgesia Following Open Thoracotomy
NCT05172570 · Indiana University · PHASE3 · terminated · last registry update 2024-03-21 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Study terminated to to shortage if study supplies for epidurals and most enrolled has study deviations due to not receiving correct post study drug assignments.” | – | Registry record, Indiana University |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CACNA1H within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2025-03-21Phase 3 first posted: Cairo University, Gabapentin 600 mg capsules + Gabapentin 400 mg capsules (NCT06887998)
- 2025-03-04Results posted on the registry: Washington University School of Medicine, Gabapentin gelatin capsules 300mg + Placebo (NCT05184192)
- 2024-12-27Results posted on the registry: Dompé Farmaceutici S.p.A, Ketoprofen Lysine Salt combined with Gabapentin + Ketoprofen Lysine Salt (NCT04802967)
- 2024-11-12Also stopped (terminated): Case Comprehensive Cancer Center, Ketamine + Placebo Ketamine (NCT04176419)
- 2024-10-23Results posted on the registry: Indiana University, Preoperative Gabapentin/Postoperative Placebo + Preoperative Gabapentin/Postoperative Gabapentin (NCT05494385)
- 2024-09-19Also stopped (withdrawn): University Hospital, Ghent, Gabapentin (NCT03747562)
- 2024-09-19Results posted on the registry: University of Alabama at Birmingham, Oxycodone + Acetaminophen (NCT03859024)
- 2024-08-19Phase 3 first posted: Campbell Clinic, Opiate Sparing + Opiate Based (NCT06561035)
- 2024-07-31Also stopped (withdrawn): University of Chicago, Gabapentin (NCT03423264)
- 2024-07-30Results posted on the registry: Arbor Pharmaceuticals, Inc., Placebo + Oxycodone 20 mg (NCT06247488)
- 2024-06-27Results posted on the registry: Sharon Walsh, Opioid Agonist + Sedatives (NCT04315181)
- 2024-04-23Results posted on the registry: Massachusetts General Hospital, Gabapentin + Sham Gabapentin (NCT01678586)
- 2024-04-18Results posted on the registry: Jacques E. Chelly, a drug against CACNA1H (NCT05252858)
- 2024-04-02Results posted on the registry: Henry Ford Health System, Celecoxib + Ketorolac (NCT03818919)
- 2024-02-14Results posted on the registry: AppliedVR Inc., multi-modality pain management (NCT04010266)
- 2024-01-31Results posted on the registry: Vanderbilt University Medical Center, Opioid Analgesic + Opioid-Free Postoperative Pain Regimen (NCT04990804)
- 2024-01-31Also stopped (terminated): Vanderbilt University Medical Center, Opioid Analgesic + Opioid-Free Postoperative Pain Regimen (NCT04990804)
- 2024-01-09Results posted on the registry: The Cleveland Clinic, Gabapentin enacarbil + Placebo (NCT02840240)
- 2024-01-03Results posted on the registry: Arbor Pharmaceuticals, Inc., Placebo + Alprazolam 2 mg (NCT06097676)
- 2023-12-28Also stopped (terminated): University of Texas Southwestern Medical Center, a drug against CACNA1H (NCT04558840)
- 2023-12-18Results posted on the registry: Cedars-Sinai Medical Center, ERAS + Standard of care (NCT03738904)
- 2023-12-13Results posted on the registry: Medical University of South Carolina, N-Acetylcysteine + Gabapentin (NCT03220776)
- 2023-12-06Results posted on the registry: Viatris Specialty LLC, gabapentin 600 mg + gabapentin 1200 mg (NCT04570436)
- 2023-10-25Also stopped (withdrawn): Massachusetts General Hospital, buprenorphine transdermal delivery system (BTDS) + Placebo for BTDS patch (NCT02138357)
- 2023-10-18Results posted on the registry: Weill Medical College of Cornell University, Gabapentin + Placebo (NCT04230980)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision